Biotechnology Stocks I Performance Guide: Amicus Therapeutics, Inc. (FOLD)
FOLD has no dividends
Table and Chart of FOLD Performance
See what a $1,000 investment in FOLD is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| FOLD Returns | |
|---|---|
| Start Date | Dec-31-2013 |
| Start Price | $2.35 |
| End Date | Dec-01-2023 |
| End Price | $11.22 |
| # Prices | 121 |
| Min Date | Mar-31-2014 |
| Min Price | $2.07 |
| Max Date | Dec-31-2020 |
| Max Price | $23.09 |
| Total Return | 377.45% |
| Annualized Return | 16.77% |
| Current Value of $1,000 Purchase | $4,774 |
| Number Returns | 7,260 |
| Average Return | 60.75% |
| Number Profitable Returns | 4,627 |
| Percent Profitable Returns | 63.73% |
| Number Unprofitable Returns | 2,633 |
| Percent Unprofitable Returns | 36.27% |
| Profitable to Unprofitable Returns Ratio | 1.76 |
| FOLD Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $3,293,149,000 | Price to Sales | 8.84 |
| Earnings per Share | $-0.5900 |
| PE Ratio | None |
| PE to Growth Ratio | -0.18 |
| Price to Book | 24.67 |
| PRICE DATA | |
| 52 Week High | $14.1 |
| 52 Week Low | $9.7 |
| Analyst Target Price | $18 |
| 50-Day Moving Average | $10.99 |
| 200-Day Moving Average | $11.98 |
| FINANCIAL DATA | |
| Revenue per Share | $1.273 |
| Revenue | $372,370,000 |
| Profit Margin | -46.6% |
| Return on Equity | -1.306% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
FOLD Compare Returns with S&P 500
FOLD Trendline Chart